Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line Treatment(ENLIGHTEN)
Clinical trial NCT05410197 · UNKNOWN
Trial details
- NCT number
- NCT05410197
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-10
- Primary completion
- 2024-08-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.